X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with Abbott India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs ABBOTT INDIA - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN LTD ABBOTT INDIA LUPIN LTD/
ABBOTT INDIA
 
P/E (TTM) x 16.8 33.1 50.8% View Chart
P/BV x 3.9 8.3 47.4% View Chart
Dividend Yield % 0.8 0.8 96.8%  

Financials

 LUPIN LTD   ABBOTT INDIA
EQUITY SHARE DATA
    LUPIN LTD
Mar-16
ABBOTT INDIA
Mar-16
LUPIN LTD/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs2,1276,015 35.4%   
Low Rs1,2943,707 34.9%   
Sales per share (Unadj.) Rs304.11,236.9 24.6%  
Earnings per share (Unadj.) Rs50.4122.2 41.2%  
Cash flow per share (Unadj.) Rs60.7129.0 47.0%  
Dividends per share (Unadj.) Rs7.5035.00 21.4%  
Dividend yield (eoy) %0.40.7 60.9%  
Book value per share (Unadj.) Rs243.8521.2 46.8%  
Shares outstanding (eoy) m450.5821.25 2,120.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.63.9 143.1%   
Avg P/E ratio x33.939.8 85.3%  
P/CF ratio (eoy) x28.237.7 74.8%  
Price / Book Value ratio x7.09.3 75.2%  
Dividend payout %14.928.6 52.0%   
Avg Mkt Cap Rs m770,740103,296 746.1%   
No. of employees `00016.43.0 553.1%   
Total wages/salary Rs m21,0773,370 625.4%   
Avg. sales/employee Rs Th8,379.68,891.8 94.2%   
Avg. wages/employee Rs Th1,289.01,140.0 113.1%   
Avg. net profit/employee Rs Th1,388.7878.3 158.1%   
INCOME DATA
Net Sales Rs m137,01626,284 521.3%  
Other income Rs m1,877504 372.1%   
Total revenues Rs m138,89326,789 518.5%   
Gross profit Rs m37,5353,665 1,024.0%  
Depreciation Rs m4,635144 3,209.8%   
Interest Rs m4468 5,508.6%   
Profit before tax Rs m34,3304,017 854.6%   
Minority Interest Rs m-880-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m11,5361,421 811.8%   
Profit after tax Rs m22,7072,596 874.6%  
Gross profit margin %27.413.9 196.4%  
Effective tax rate %33.635.4 95.0%   
Net profit margin %16.69.9 167.8%  
BALANCE SHEET DATA
Current assets Rs m97,79014,446 676.9%   
Current liabilities Rs m53,8724,725 1,140.2%   
Net working cap to sales %32.137.0 86.7%  
Current ratio x1.83.1 59.4%  
Inventory Days Days8551 164.8%  
Debtors Days Days12120 619.7%  
Net fixed assets Rs m86,3791,113 7,761.6%   
Share capital Rs m901213 424.1%   
"Free" reserves Rs m105,73510,808 978.3%   
Net worth Rs m109,84411,076 991.7%   
Long term debt Rs m53,7390-   
Total assets Rs m224,37816,241 1,381.6%  
Interest coverage x77.9497.0 15.7%   
Debt to equity ratio x0.50-  
Sales to assets ratio x0.61.6 37.7%   
Return on assets %10.316.0 64.3%  
Return on equity %20.723.4 88.2%  
Return on capital %21.236.3 58.4%  
Exports to sales %49.10.6 7,982.4%   
Imports to sales %7.412.6 58.9%   
Exports (fob) Rs m67,244162 41,611.3%   
Imports (cif) Rs m10,1993,322 307.0%   
Fx inflow Rs m71,405268 26,643.6%   
Fx outflow Rs m17,8073,927 453.4%   
Net fx Rs m53,598-3,659 -1,464.7%   
CASH FLOW
From Operations Rs m-3,6902,514 -146.7%  
From Investments Rs m-69,434-800 8,684.7%  
From Financial Activity Rs m58,126-803 -7,239.5%  
Net Cashflow Rs m-14,998912 -1,644.7%  

Share Holding

Indian Promoters % 46.6 0.0 -  
Foreign collaborators % 0.2 75.0 0.3%  
Indian inst/Mut Fund % 11.3 7.9 143.0%  
FIIs % 31.9 0.1 31,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 17.1 59.1%  
Shareholders   98,259 18,270 537.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN LTD With:   GLENMARK PHARMA  FULFORD INDIA  MERCK LTD  DIVIS LABORATORIES  J.B.CHEMICALS  

Compare LUPIN LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Aug 17, 2017 (Close)

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE LUPIN LTD WITH

MARKET STATS